Breaking News Instant updates and real-time market news.

SNAP

Snap

$14.00

-0.58 (-3.98%)

06:14
10/23/19
10/23
06:14
10/23/19
06:14

Barclays ups Snap target to $20 after upbeat conference call

Snap last night reported daily active users, revenue and EBITDA that were 3M, 3%, and $20M above consensus and sounded upbeat on its conference call, Barclays analyst Ross Sandler tells investors in a research note. He believes the consistency of Snap's results and communication are "likely to inspire confidence in the investment community over time." The analyst would add to positions on any weakness and boosted his price target for the shares to $20 from $19. Sandler keeps an Overweight rating on Snap.

  • 21

    Nov

SNAP Snap
$14.00

-0.58 (-3.98%)

10/21/19
FBCO
10/21/19
NO CHANGE
Target $21
FBCO
Outperform
Snap ads forecast raised for Q3 at Credit Suisse
Credit Suisse analyst Stephen Ju has raised his Snap Ads forecast for Q3 by $10M based on positive feedback from advertisers. The analyst believes Snap has come full circle to begin delivering on the investment thesis at the time of its public offering and he is looking forward to a sustained period of lower gyrations to its users along with revenue growth driven by primarily ad impressions. Ju reiterates an Outperform rating for Snap, while raising his price target on the shares to $21 from $20 given potential for better-than-expected user growth with a revamped Android app released in more geographies, potential for better-than-expected ad revenue on ramping ad load growth, and as Snap is a scarce asset that offers advertisers access to a coveted younger demographic.
10/21/19
LITP
10/21/19
INITIATION
Target $20
LITP
Buy
Snap initiated with a Buy at LightShed Partners
LightShed Partners analyst Rich Greenfield initiated coverage of Snap with a Buy rating and $20 price target. In June, when formerly with BTIG, Greenfield had raised his price target on Snap to $20 and kept his Buy rating on the stock.
10/21/19
CLVD
10/21/19
NO CHANGE
CLVD
Snap advertiser outlook seen getting more bullish, says Cleveland Research
Cleveland Research analyst Chandler Converse said his channel checks indicate that advertisers' outlook on Snap (SNAP) appears more bullish in recent feedback, adding that Q3 "sounds stronger than expected" as the company seems to be executing better. Converse also said in a note on social advertising checks that Pinterest (PINS) partners point to growing advertisers and strong pipelines of net new clients. Converse does not have ratings on Snap or Pinterest shares.
10/23/19
JPMS
10/23/19
UPGRADE
Target $20
JPMS
Overweight
Snap upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Doug Anmuth upgraded Snap to Overweight from Neutral with a $20 price target.

TODAY'S FREE FLY STORIES

SCPH

scPharmaceuticals

$5.26

0.11 (2.14%)

08:13
11/12/19
11/12
08:13
11/12/19
08:13
Hot Stocks
scPharmaceuticals expects 2019 cash, cash equivalents $65M-$70M »

Based on its current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCPH

scPharmaceuticals

$5.26

0.11 (2.14%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Earnings
scPharmaceuticals reports Q3 EPS (31c), consensus (45c) »

"We continue to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Hot Stocks
Amarin jumps as FDA posts documents for Vascepa advisory committee meeting »

Shares of Amarin (AMRN)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

CBMG

Cellular Biomedicine

$17.86

0.11 (0.62%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Downgrade
Cellular Biomedicine rating change  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCNX

Vaccinex

$5.05

0.19 (3.91%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Earnings
Vaccinex reports Q3 revenue $404,000, consensus 30,000 »

"The highlight of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$4.08

-0.015 (-0.37%)

, BIOX

Bioceres

$5.70

-0.2 (-3.39%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
Verdeca receives approval of HB4 drought and herbicide tolerant soybeans »

Verdeca, a joint venture…

RKDA

Arcadia Biosciences

$4.08

-0.015 (-0.37%)

BIOX

Bioceres

$5.70

-0.2 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NH

NantHealth

$0.70

0.008 (1.16%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
NantHealth reports FDA marketing authorization of Omics Core »

NantHealth reported FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
Amarin soars after FDA posts briefing docs ahead of Nov. 14 panel »

Shares of Amarin are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

SWTX

SpringsWorks Therapeutics

$18.42

-0.1 (-0.54%)

08:10
11/12/19
11/12
08:10
11/12/19
08:10
Earnings
SpringsWorks Therapeutics reports Q3 EPS ($1.77), consensus (47c) »

"The third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNE

Clean Energy

$2.23

-0.01 (-0.45%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Earnings
Clean Energy reports Q3 EPS (2c), consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HON

Honeywell

$180.73

-0.48 (-0.26%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Hot Stocks
Honeywell Process Solutions selected by Kuwait Integrated Petroleum Industries »

Honeywell announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.30

-0.095 (-6.81%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Hot Stocks
Cellectar Biosciences expects cash to fund operations into 1Q21 »

As of September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.30

-0.095 (-6.81%)

08:08
11/12/19
11/12
08:08
11/12/19
08:08
Earnings
Cellectar Biosciences reports Q3 EPS (42c), consensus (38c) »

"We continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.05

-0.02 (-1.87%)

08:08
11/12/19
11/12
08:08
11/12/19
08:08
Hot Stocks
Moleculin Biotech receives FDA approval for IND of WP1066 »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LOGC

LogicBio Therapeutics

$9.49

0.09 (0.96%)

08:07
11/12/19
11/12
08:07
11/12/19
08:07
Hot Stocks
LogicBio Therapeutics expects cash to fund operations into 2021 »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGC

LogicBio Therapeutics

$9.49

0.09 (0.96%)

08:07
11/12/19
11/12
08:07
11/12/19
08:07
Earnings
LogicBio Therapeutics reports Q3 EPS (48c), consensus (46c) »

"This has been a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin jumps 7% to $18.13…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

MPAA

Motorcar Parts

$19.96

-0.66 (-3.20%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Earnings
Motorcar Parts reports Q2 adj. EPS 68c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FATE

Fate Therapeutics

$14.49

-0.09 (-0.62%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Initiation
Fate Therapeutics initiated  »

Fate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LM

Legg Mason

$38.33

0.17 (0.45%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
Legg Mason reports AUM of $791.0B as of October 31 »

Legg Mason reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$39.21

1.09 (2.86%)

, VIA

Viacom

$26.40

0.87 (3.41%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
CBS, Viacom merger expected to close in early December »

On August 13, CBS (CBS)…

CBS

CBS

$39.21

1.09 (2.86%)

VIA

Viacom

$26.40

0.87 (3.41%)

VIAB

Viacom

$23.46

0.71 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

08:05
11/12/19
11/12
08:05
11/12/19
08:05
Conference/Events
Craig-Hallum to hold a conference »

10th Annual Craig-Hallum…

MJARF

MJardin Group

$0.00

(0.00%)

08:05
11/12/19
11/12
08:05
11/12/19
08:05
Hot Stocks
MJardin Group announces partnership with Robes Inc. »

MJardin Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

RUBY

Rubius Therapeutics

$10.91

-0.13 (-1.18%)

, SYBX

Synlogic

$2.28

-0.015 (-0.66%)

08:04
11/12/19
11/12
08:04
11/12/19
08:04
Hot Stocks
Rubius Therapeutics appoints Maiken Keson-Brookes as CLO »

Rubius Therapeutics…

RUBY

Rubius Therapeutics

$10.91

-0.13 (-1.18%)

SYBX

Synlogic

$2.28

-0.015 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

PBI

Pitney Bowes

$4.95

-0.14 (-2.75%)

08:04
11/12/19
11/12
08:04
11/12/19
08:04
Hot Stocks
Pitney Bowes announces partnership with Luxer One »

Pitney Bowes announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.